United States Healthcare Providers & Services

Elevance Health Inc (ELV)

Track

In the last 90 days, Elevance Health Inc. has seen net insider selling totaling over $617,000, primarily from officers. This activity contrasts with earlier buying trends observed in the past year. The stock has performed strongly, with a 90-day price increase of 37.2%, nearing its 52-week high.

Top insider sells (90, 60, 30d)

Top cluster sells (90, 60, 30d)

Featured in screeners

Top insider sells

Top cluster sells

Stock chart

Ticker: ELV Exchange: NYS

Subscribe to get access to the transaction volume chart and in-chart transaction details

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings

Top insiders

Company data & Insiders

Subscribe to get access to the company description and key fundamental data (market cap, shares outstanding, dividend yield, % of shares held by insiders and more)

Download results Settings

Trades

Penczek Ronald W

CAO & Controller

1 sale — total 100,000 USD

Sale 12 Jun 2026

Value US$2,429,862.78 | Price 438.99 | Shares 47,633

RONALD WILLIAM PENCZEK

Officer

1 sale — total 100,000 USD

Proposed sale 12 Jun 2026

Value US$1,373,331.19 | Price 422.43 | Shares 71,141

Dixon Robert L JR

3 sales — total 300,000 USD

Sale 11 Jun 2026

Value US$100,000.00 | Price 401.77 | Shares 1,000

Sale 11 Jun 2026

Value US$100,000.00 | Price 401.77 | Shares 1,000

Proposed sale 11 Jun 2026

Value US$100,000.00 | Price 401.76 | Shares 1,000

Penczek Ronald W

CAO & Controller

1 sale — total 617,192 USD

Sale 19 May 2026

Value US$617,192.03 | Price 403.13 | Shares 1,531

RONALD WILLIAM PENCZEK

Officer

1 sale — total 617,192 USD

Proposed sale 19 May 2026

Value US$617,192.18 | Price 403.13 | Shares 1,531

SCHULMAN AMY W

1 sale — total 7,475 USD

Sale 12 Mar 2026

Value US$7,475.00 | Price 287.50 | Shares 26

Kendrick Charles Morgan JR

EVP & President, Commercial

1 sale — total 910,604 USD

Sale 6 Mar 2026

Value US$910,604.32 | Price 284.92 | Shares 3,196

CHARLES MORGAN KENDRICK

Officer

1 sale — total 910,593 USD

Proposed sale 6 Mar 2026

Value US$910,593.13 | Price 284.92 | Shares 3,196

COLLIS STEVEN H

1 purchase — total 869,520 USD

Buy 5 Mar 2026

Value US$869,520.00 | Price 289.84 | Shares 3,000

DeVore Susan D.

1 purchase — total 374,580 USD

Buy 19 Aug 2025

Value US$374,580.00 | Price 312.15 | Shares 1,200

BOUDREAUX GAIL

President and CEO

3 purchases — total 2,438,951 USD

Buy 18 Jul 2025

Value US$302,358.00 | Price 287.96 | Shares 1,050

Buy 18 Jul 2025

Value US$1,468,905.92 | Price 287.12 | Shares 5,116

Buy 18 Jul 2025

Value US$667,687.38 | Price 286.07 | Shares 2,334

Kaye Mark

EVP & CFO

2 sales — total 3,898,125 USD

Sale 24 Apr 2025

Value US$1,949,074.16 | Price 424.82 | Shares 4,588

Proposed sale 24 Apr 2025

Value US$1,949,051.22 | Price 424.82 | Shares 4,588

Penczek Ronald W

CAO & Controller

2 sales — total 367,807 USD

Sale 10 Mar 2025

Value US$183,902.59 | Price 415.13 | Shares 443

Proposed sale 10 Mar 2025

Value US$183,904.36 | Price 415.13 | Shares 443

Kendrick Charles Morgan JR

Officer

2 sales — total 2,777,287 USD

Proposed sale 5 Mar 2025

Value US$1,388,651.32 | Price 396.30 | Shares 3,504

Sale 5 Mar 2025

Value US$1,388,635.20 | Price 396.30 | Shares 3,504

Kendrick Charles Morgan JR

Director

2 sales — total 6,411,403 USD

Proposed sale 18 Oct 2024

Value US$3,206,220.76 | Price 432.28 | Shares 7,417

Sale 18 Oct 2024

Value US$3,205,182.38 | Price 432.14 | Shares 7,417

PERU RAMIRO G

1 sale — total 400,235 USD

Planned sale 5 Aug 2024

Value US$400,234.56 | Price 531.52 | Shares 753

RAMIRO G PERU

Director

1 sale — total 400,235 USD

Proposed sale 5 Aug 2024

Value US$400,234.56 | Price 531.52 | Shares 753

BOUDREAUX GAIL

President and CEO

6 sales — total 17,033,395 USD

Planned sale 22 Jul 2024

Value US$1,134,607.50 | Price 504.27 | Shares 2,250

Planned sale 22 Jul 2024

Value US$503,670.00 | Price 503.67 | Shares 1,000

Planned sale 22 Jul 2024

Value US$1,130,017.50 | Price 502.23 | Shares 2,250

Planned sale 22 Jul 2024

Value US$3,319,769.40 | Price 501.40 | Shares 6,621

Planned sale 22 Jul 2024

Value US$10,396,980.44 | Price 500.36 | Shares 20,779

Planned sale 22 Jul 2024

Value US$548,350.00 | Price 498.50 | Shares 1,100

GAIL A KOZIARA BOUDREAUX

Officer; Director

1 sale — total 17,033,398 USD

Proposed sale 22 Jul 2024

Value US$17,033,398.20 | Price 500.98 | Shares 34,000

Dixon Robert L JR

1 sale — total 154,562 USD

Sale 19 Jul 2024

Value US$154,561.80 | Price 506.76 | Shares 305

ROBERT DIXON

Director

1 sale — total 154,562 USD

Proposed sale 19 Jul 2024

Value US$154,561.80 | Price 506.76 | Shares 305

Norwood Felicia F

EVP & President,Gov Health Ben

2 sales — total 3,300,590 USD

Sale 24 Apr 2024

Value US$1,829,223.12 | Price 532.68 | Shares 3,434

Sale 24 Apr 2024

Value US$1,471,367.10 | Price 532.14 | Shares 2,765

Norwood Felicia F

EVP & President,Gov Health Ben

3 sales — total 18,368,981 USD

Sale 23 Apr 2024

Value US$53,474.00 | Price 534.74 | Shares 100

Sale 23 Apr 2024

Value US$7,478,091.03 | Price 533.73 | Shares 14,011

Proposed sale 23 Apr 2024

Value US$10,837,416.00 | Price 533.60 | Shares 20,310

Kendrick Charles Morgan JR

EVP & President, Commercial

2 sales — total 2,434,237 USD

Sale 8 Mar 2024

Value US$1,217,118.72 | Price 500.46 | Shares 2,432

Proposed sale 8 Mar 2024

Value US$1,217,118.72 | Price 500.46 | Shares 2,432

Penczek Ronald W

CAO & Controller

2 sales — total 924,392 USD

Sale 6 Mar 2024

Value US$462,195.28 | Price 504.58 | Shares 916

Proposed sale 6 Mar 2024

Value US$462,196.89 | Price 504.58 | Shares 916

Haytaian Peter D

EVP & Pres Carelon & CarelonRx

3 sales — total 10,551,297 USD

Planned sale 4 Mar 2024

Value US$7,502,700.00 | Price 500.18 | Shares 15,000

Planned sale 4 Mar 2024

Value US$944,840.02 | Price 500.18 | Shares 1,889

Planned sale 4 Mar 2024

Value US$2,103,757.08 | Price 500.18 | Shares 4,206

PETER D HAYTAIAN

Officer

1 sale — total 10,551,297 USD

Proposed sale 4 Mar 2024

Value US$10,551,297.10 | Price 500.18 | Shares 21,095

PERU RAMIRO G

1 sale — total 376,500 USD

Planned sale 7 Feb 2024

Value US$376,500.00 | Price 500.00 | Shares 753

RAMIRO G PERU

Director

1 sale — total 376,500 USD

Proposed sale 7 Feb 2024

Value US$376,500.00 | Price 500.00 | Shares 753

Todt Blair Williams

EVP, CLO & CAO

2 sales — total 5,316,476 USD

Sale 14 Dec 2023

Value US$2,658,237.84 | Price 484.02 | Shares 5,492

Proposed sale 14 Dec 2023

Value US$2,658,237.84 | Price 484.02 | Shares 5,492

Penczek Ronald W

CAO & Controller

2 sales — total 1,002,605 USD

Sale 30 Nov 2023

Value US$501,304.35 | Price 475.17 | Shares 1,055

Proposed sale 30 Nov 2023

Value US$501,300.17 | Price 475.17 | Shares 1,055

Penczek Ronald W

CAO & Controller

1 sale — total 29,078 USD

Sale 24 Oct 2023

Value US$29,078.40 | Price 454.35 | Shares 64

ROBERT DIXON JR

Director

1 sale — total 147,781 USD

Proposed sale 21 Jul 2023

Value US$147,780.66 | Price 476.71 | Shares 310

Dixon Robert L JR

1 sale — total 147,780 USD

Sale 21 Jul 2023

Value US$147,780.10 | Price 476.71 | Shares 310

MCCARTHY GLORIA M

EVP & Chief Administrative Off

6 sales — total 6,714,978 USD

Planned sale 24 Mar 2023

Value US$1,616,967.50 | Price 446.06 | Shares 3,625

Planned sale 24 Mar 2023

Value US$2,481,656.90 | Price 445.30 | Shares 5,573

Planned sale 24 Mar 2023

Value US$1,332,990.00 | Price 444.33 | Shares 3,000

Planned sale 24 Mar 2023

Value US$797,886.00 | Price 443.27 | Shares 1,800

Planned sale 24 Mar 2023

Value US$221,010.00 | Price 442.02 | Shares 500

Planned sale 24 Mar 2023

Value US$264,468.00 | Price 440.78 | Shares 600

Kendrick Charles Morgan JR

EVP & President, Commercial

1 sale — total 1,069,577 USD

Sale 9 Mar 2023

Value US$1,069,577.08 | Price 462.22 | Shares 2,314

Kendrick Charles Morgan JR

EVP & President, Commercial

5 sales — total 3,091,872 USD

Sale 9 Jun 2022

Value US$101,226.34 | Price 491.39 | Shares 206

Sale 9 Jun 2022

Value US$256,213.26 | Price 490.83 | Shares 522

Sale 9 Jun 2022

Value US$383,760.16 | Price 489.49 | Shares 784

Sale 9 Jun 2022

Value US$1,278,282.24 | Price 488.64 | Shares 2,616

Sale 9 Jun 2022

Value US$1,072,390.00 | Price 487.45 | Shares 2,200

Dixon Robert L JR

1 sale — total 208,799 USD

Sale 6 Jun 2022

Value US$208,798.80 | Price 497.14 | Shares 420

PERU RAMIRO G

1 sale — total 464,191 USD

Planned sale 19 May 2022

Value US$464,191.20 | Price 468.88 | Shares 990

Haytaian Peter D

EVP & Pres., DBG & IngenioRx

5 sales — total 7,160,527 USD

Planned sale 10 Mar 2022

Value US$18,536.00 | Price 463.40 | Shares 40

Planned sale 10 Mar 2022

Value US$573,785.20 | Price 462.73 | Shares 1,240

Planned sale 10 Mar 2022

Value US$2,712,143.28 | Price 461.72 | Shares 5,874

Planned sale 10 Mar 2022

Value US$1,891,091.40 | Price 460.68 | Shares 4,105

Planned sale 10 Mar 2022

Value US$1,964,971.50 | Price 459.75 | Shares 4,274

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Value
2026-06-15	2026-06-12	S Sale	2.7 Penczek Ronald W CAO & Controller Officer	47,633 +9.6% 438.99 US$2,429,863	47,633 +9.6%	438.99	US$2,429,863
2026-06-12	2026-06-12	PrS Proposed sale	2.7 RONALD WILLIAM PENCZEK Officer Officer	71,141 422.43 US$1,373,331	71,141	422.43	US$1,373,331
2026-06-12	2026-06-11	S Sale	3.6 Dixon Robert L JR Non-Executive Director	74,672 -21.8% 467.91 US$107,011	74,672 -21.8%	467.91	US$107,011
2026-06-12	2026-06-11	S Sale	3.6 Dixon Robert L JR Non-Executive Director	1,000 -1.4% 401.77 US$100,000	1,000 -1.4%	401.77	US$100,000
2026-06-11	2026-06-11	PrS Proposed sale	3.6 Dixon Robert L JR Director Non-Executive Director	1,000 401.76 US$100,000	1,000	401.76	US$100,000
2026-05-20	2026-05-19	S Sale	2.7 Penczek Ronald W CAO & Controller Officer	1,531 -27.1% 403.13 US$617,192	1,531 -27.1%	403.13	US$617,192
2026-05-19	2026-05-19	PrS Proposed sale	2.7 RONALD WILLIAM PENCZEK Officer Officer	1,531 403.13 US$617,192	1,531	403.13	US$617,192
2026-03-23	2026-03-12	S Sale	2.6 SCHULMAN AMY W Non-Executive Director	26 -10.7% 287.50 US$7,475	26 -10.7%	287.50	US$7,475
2026-03-09	2026-03-06	S Sale	3.3 Kendrick Charles Morgan JR EVP & President, Commercial Officer	3,196 -21.3% 284.92 US$910,604	3,196 -21.3%	284.92	US$910,604
2026-03-06	2026-03-06	PrS Proposed sale	3.3 CHARLES MORGAN KENDRICK Officer Officer	3,196 284.92 US$910,593	3,196	284.92	US$910,593
2026-03-06	2026-03-05	B Purchase	2.9 COLLIS STEVEN H Non-Executive Director	3,000 +469.5% 289.84 US$869,520	3,000 +469.5%	289.84	US$869,520
2025-08-21	2025-08-19	B Purchase	2.1 DeVore Susan D. Non-Executive Director	1,200 +52.1% 312.15 US$374,580	1,200 +52.1%	312.15	US$374,580
2025-07-18	2025-07-18	B Purchase	3.7 BOUDREAUX GAIL President and CEO Executive Director	1,050 +0.7% 287.96 US$302,358	1,050 +0.7%	287.96	US$302,358
2025-07-18	2025-07-18	B Purchase	3.7 BOUDREAUX GAIL President and CEO Executive Director	5,116 +3.5% 287.12 US$1,468,906	5,116 +3.5%	287.12	US$1,468,906
2025-07-18	2025-07-18	B Purchase	3.7 BOUDREAUX GAIL President and CEO Executive Director	2,334 +1.6% 286.07 US$667,687	2,334 +1.6%	286.07	US$667,687
2025-04-25	2025-04-24	S Sale	2.7 Kaye Mark EVP & CFO Officer	4,588 -19.5% 424.82 US$1,949,074	4,588 -19.5%	424.82	US$1,949,074
2025-04-24	2025-04-24	PrS Proposed sale	2.7 Kaye Mark Officer Officer	4,588 424.82 US$1,949,051	4,588	424.82	US$1,949,051
2025-03-11	2025-03-10	S Sale	2.7 Penczek Ronald W CAO & Controller Officer	443 -19.3% 415.13 US$183,903	443 -19.3%	415.13	US$183,903
2025-03-10	2025-03-10	PrS Proposed sale	2.7 Penczek Ronald W Officer Officer	443 415.13 US$183,904	443	415.13	US$183,904
2025-03-05	2025-03-05	PrS Proposed sale	3.3 Kendrick Charles Morgan JR Officer Officer	3,504 396.30 US$1,388,651	3,504	396.30	US$1,388,651
2025-03-05	2025-03-05	S Sale	3.3 Kendrick Charles Morgan JR EVP & President, Commercial Officer	3,504 -25.7% 396.30 US$1,388,635	3,504 -25.7%	396.30	US$1,388,635
2024-10-18	2024-10-18	PrS Proposed sale	3.3 Kendrick Charles Morgan JR Director Non-Executive Director	7,417 432.28 US$3,206,221	7,417	432.28	US$3,206,221
2024-10-18	2024-10-18	S Sale	3.3 Kendrick Charles Morgan JR EVP & President, Commercial Officer	7,417 -46.8% 432.14 US$3,205,182	7,417 -46.8%	432.14	US$3,205,182
2024-08-06	2024-08-05	PlS Planned sale	3.5 PERU RAMIRO G Non-Executive Director	753 -7.9% 531.52 US$400,235	753 -7.9%	531.52	US$400,235
2024-08-05	2024-08-05	PrS Proposed sale	3.5 RAMIRO G PERU Director Non-Executive Director	753 531.52 US$400,235	753	531.52	US$400,235
2024-07-23	2024-07-22	PlS Planned sale	3.7 BOUDREAUX GAIL President and CEO Executive Director	2,250 -1.7% 504.27 US$1,134,608	2,250 -1.7%	504.27	US$1,134,608
2024-07-23	2024-07-22	PlS Planned sale	3.7 BOUDREAUX GAIL President and CEO Executive Director	1,000 -0.8% 503.67 US$503,670	1,000 -0.8%	503.67	US$503,670
2024-07-23	2024-07-22	PlS Planned sale	3.7 BOUDREAUX GAIL President and CEO Executive Director	2,250 -1.7% 502.23 US$1,130,018	2,250 -1.7%	502.23	US$1,130,018
2024-07-23	2024-07-22	PlS Planned sale	3.7 BOUDREAUX GAIL President and CEO Executive Director	6,621 -4.8% 501.40 US$3,319,769	6,621 -4.8%	501.40	US$3,319,769
2024-07-23	2024-07-22	PlS Planned sale	3.7 BOUDREAUX GAIL President and CEO Executive Director	20,779 -13.0% 500.36 US$10,396,980	20,779 -13.0%	500.36	US$10,396,980
2024-07-23	2024-07-22	PlS Planned sale	3.7 BOUDREAUX GAIL President and CEO Executive Director	1,100 -0.7% 498.50 US$548,350	1,100 -0.7%	498.50	US$548,350
2024-07-22	2024-07-22	PrS Proposed sale	3.7 GAIL A KOZIARA BOUDREAUX Officer; Director Executive Director	34,000 500.98 US$17,033,398	34,000	500.98	US$17,033,398
2024-07-22	2024-07-19	S Sale	3.6 Dixon Robert L JR Non-Executive Director	305 -3.0% 506.76 US$154,562	305 -3.0%	506.76	US$154,562
2024-07-19	2024-07-19	PrS Proposed sale	3.6 ROBERT DIXON Director Non-Executive Director	305 506.76 US$154,562	305	506.76	US$154,562
2024-04-25	2024-04-24	S Sale	2.1 Norwood Felicia F EVP & President,Gov Health Ben Officer	3,434 -11.2% 532.68 US$1,829,223	3,434 -11.2%	532.68	US$1,829,223
2024-04-25	2024-04-24	S Sale	2.1 Norwood Felicia F EVP & President,Gov Health Ben Officer	2,765 -8.3% 532.14 US$1,471,367	2,765 -8.3%	532.14	US$1,471,367
2024-04-25	2024-04-23	S Sale	2.1 Norwood Felicia F EVP & President,Gov Health Ben Officer	100 -0.3% 534.74 US$53,474	100 -0.3%	534.74	US$53,474
2024-04-25	2024-04-23	S Sale	2.1 Norwood Felicia F EVP & President,Gov Health Ben Officer	14,011 -30.7% 533.73 US$7,478,091	14,011 -30.7%	533.73	US$7,478,091
2024-04-23	2024-04-23	PrS Proposed sale	2.1 Norwood Felicia F Officer Officer	20,310 533.60 US$10,837,416	20,310	533.60	US$10,837,416
2024-03-12	2024-03-08	S Sale	3.3 Kendrick Charles Morgan JR EVP & President, Commercial Officer	2,432 -13.3% 500.46 US$1,217,119	2,432 -13.3%	500.46	US$1,217,119
2024-03-08	2024-03-08	PrS Proposed sale	3.3 Kendrick Charles Morgan JR Officer Officer	2,432 500.46 US$1,217,119	2,432	500.46	US$1,217,119
2024-03-08	2024-03-06	S Sale	2.7 Penczek Ronald W CAO & Controller Officer	916 -34.2% 504.58 US$462,195	916 -34.2%	504.58	US$462,195
2024-03-06	2024-03-06	PrS Proposed sale	2.7 Penczek Ronald W Officer Officer	916 504.58 US$462,197	916	504.58	US$462,197
2024-03-05	2024-03-04	PlS Planned sale	1.4 Haytaian Peter D EVP & Pres Carelon & CarelonRx Officer	15,000 -44.3% 500.18 US$7,502,700	15,000 -44.3%	500.18	US$7,502,700
2024-03-05	2024-03-04	PlS Planned sale	1.4 Haytaian Peter D EVP & Pres Carelon & CarelonRx Officer	1,889 -5.3% 500.18 US$944,840	1,889 -5.3%	500.18	US$944,840
2024-03-05	2024-03-04	PlS Planned sale	1.4 Haytaian Peter D EVP & Pres Carelon & CarelonRx Officer	4,206 -10.5% 500.18 US$2,103,757	4,206 -10.5%	500.18	US$2,103,757
2024-03-04	2024-03-04	PrS Proposed sale	1.4 PETER D HAYTAIAN Officer Officer	21,095 500.18 US$10,551,297	21,095	500.18	US$10,551,297
2024-02-09	2024-02-07	PlS Planned sale	3.5 PERU RAMIRO G Non-Executive Director	753 -7.6% 500.00 US$376,500	753 -7.6%	500.00	US$376,500
2024-02-07	2024-02-07	PrS Proposed sale	3.5 RAMIRO G PERU Director Non-Executive Director	753 500.00 US$376,500	753	500.00	US$376,500
2023-12-15	2023-12-14	S Sale	1.6 Todt Blair Williams EVP, CLO & CAO Officer	5,492 -30.5% 484.02 US$2,658,238	5,492 -30.5%	484.02	US$2,658,238
2023-12-14	2023-12-14	PrS Proposed sale	1.6 Todt Blair Williams Officer Officer	5,492 484.02 US$2,658,238	5,492	484.02	US$2,658,238
2023-12-01	2023-11-30	S Sale	2.7 Penczek Ronald W CAO & Controller Officer	1,055 -37.1% 475.17 US$501,304	1,055 -37.1%	475.17	US$501,304
2023-11-30	2023-11-30	PrS Proposed sale	2.7 Penczek Ronald W Officer Officer	1,055 475.17 US$501,300	1,055	475.17	US$501,300
2023-10-26	2023-10-24	S Sale	2.7 Penczek Ronald W CAO & Controller Officer	64 -2.2% 454.35 US$29,078	64 -2.2%	454.35	US$29,078
2023-07-21	2023-07-21	PrS Proposed sale	3.6 ROBERT DIXON JR Director Non-Executive Director	310 476.71 US$147,781	310	476.71	US$147,781
2023-07-21	2023-07-21	S Sale	3.6 Dixon Robert L JR Non-Executive Director	310 -3.1% 476.71 US$147,780	310 -3.1%	476.71	US$147,780
2023-03-27	2023-03-24	PlS Planned sale	MCCARTHY GLORIA M EVP & Chief Administrative Off Officer	3,625 -6.6% 446.06 US$1,616,968	3,625 -6.6%	446.06	US$1,616,968
2023-03-27	2023-03-24	PlS Planned sale	MCCARTHY GLORIA M EVP & Chief Administrative Off Officer	5,573 -9.2% 445.30 US$2,481,657	5,573 -9.2%	445.30	US$2,481,657
2023-03-27	2023-03-24	PlS Planned sale	MCCARTHY GLORIA M EVP & Chief Administrative Off Officer	3,000 -4.7% 444.33 US$1,332,990	3,000 -4.7%	444.33	US$1,332,990
2023-03-27	2023-03-24	PlS Planned sale	MCCARTHY GLORIA M EVP & Chief Administrative Off Officer	1,800 -2.8% 443.27 US$797,886	1,800 -2.8%	443.27	US$797,886
2023-03-27	2023-03-24	PlS Planned sale	MCCARTHY GLORIA M EVP & Chief Administrative Off Officer	500 -0.8% 442.02 US$221,010	500 -0.8%	442.02	US$221,010
2023-03-27	2023-03-24	PlS Planned sale	MCCARTHY GLORIA M EVP & Chief Administrative Off Officer	600 -0.9% 440.78 US$264,468	600 -0.9%	440.78	US$264,468
2023-03-13	2023-03-09	S Sale	3.3 Kendrick Charles Morgan JR EVP & President, Commercial Officer	2,314 -13.1% 462.22 US$1,069,577	2,314 -13.1%	462.22	US$1,069,577
2022-06-13	2022-06-09	S Sale	3.3 Kendrick Charles Morgan JR EVP & President, Commercial Officer	206 -1.4% 491.39 US$101,226	206 -1.4%	491.39	US$101,226
2022-06-13	2022-06-09	S Sale	3.3 Kendrick Charles Morgan JR EVP & President, Commercial Officer	522 -3.4% 490.83 US$256,213	522 -3.4%	490.83	US$256,213
2022-06-13	2022-06-09	S Sale	3.3 Kendrick Charles Morgan JR EVP & President, Commercial Officer	784 -4.9% 489.49 US$383,760	784 -4.9%	489.49	US$383,760
2022-06-13	2022-06-09	S Sale	3.3 Kendrick Charles Morgan JR EVP & President, Commercial Officer	2,616 -14.0% 488.64 US$1,278,282	2,616 -14.0%	488.64	US$1,278,282
2022-06-13	2022-06-09	S Sale	3.3 Kendrick Charles Morgan JR EVP & President, Commercial Officer	2,200 -10.5% 487.45 US$1,072,390	2,200 -10.5%	487.45	US$1,072,390
2022-06-07	2022-06-06	S Sale	3.6 Dixon Robert L JR Non-Executive Director	420 -4.2% 497.14 US$208,799	420 -4.2%	497.14	US$208,799
2022-05-20	2022-05-19	PlS Planned sale	3.5 PERU RAMIRO G Non-Executive Director	990 -9.5% 468.88 US$464,191	990 -9.5%	468.88	US$464,191
2022-03-14	2022-03-10	PlS Planned sale	1.4 Haytaian Peter D EVP & Pres., DBG & IngenioRx Officer	40 -0.3% 463.40 US$18,536	40 -0.3%	463.40	US$18,536
2022-03-14	2022-03-10	PlS Planned sale	1.4 Haytaian Peter D EVP & Pres., DBG & IngenioRx Officer	1,240 -9.2% 462.73 US$573,785	1,240 -9.2%	462.73	US$573,785
2022-03-14	2022-03-10	PlS Planned sale	1.4 Haytaian Peter D EVP & Pres., DBG & IngenioRx Officer	5,874 -30.4% 461.72 US$2,712,143	5,874 -30.4%	461.72	US$2,712,143
2022-03-14	2022-03-10	PlS Planned sale	1.4 Haytaian Peter D EVP & Pres., DBG & IngenioRx Officer	4,105 -17.5% 460.68 US$1,891,091	4,105 -17.5%	460.68	US$1,891,091
2022-03-14	2022-03-10	PlS Planned sale	1.4 Haytaian Peter D EVP & Pres., DBG & IngenioRx Officer	4,274 -15.4% 459.75 US$1,964,972	4,274 -15.4%	459.75	US$1,964,972